Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection

Frater J., Ewer K., Ogbe A., Pace M., Adele S., Adland E., Alagaratnam J., Aley PK., Ali M., Ansari MA., Bara A., Bittaye M., Broadhead S., Brown A., Brown H., Cappuccini F., Cooney E., Dejnirattisai W., Dold C., Fairhead C., Fok H., Folegatti PM., Fowler J., Gibbs C., Goodman AL., Jenkin D., Jones M., Makinson R., Marchevsky NG., Farooq Mujadidi Y., Nguyen H., Parolini L., Petersen C., Plested E., Pollock KM., Ramasamy MN., Rhead S., Robinson H., Robinson N., Rongkard P., Ryan F., Serrano S., Stockmann H., Tipoe T., Voysey M., Waters A., Zacharopoulou P., Barnes E., Dunachie S., Goulder P., Klenerman P., Screaton G., Winston A., Hill AVS., Gilbert SC., Pollard A., Fidler S., Fox J., Lambe T., Group OCOVIDVT.

DOI

10.2139/ssrn.3829931

Type

Preprint

Publication Date

23/04/2021

Permalink Original publication